Eli Lilly and Company: Small Cell Lung Carcinoma trials
The registry lists 12 Small Cell Lung Carcinoma studies with Eli Lilly and Company as lead sponsor. 0 are open to participants now and 9 have results posted.
Phase 1 5Phase 2 8Phase 3 2(a study in two phases counts in both)
Studies
Open to participants first, then studies with results posted, then the rest; newest registration first within each.
- A Study of AK-01 (LY3295668) in Solid TumorsCompletedNCT03092934Phase 1/2Results posted
- A Study of Prexasertib (LY2606368) in Participants With Extensive Stage Disease Small Cell Lung CancerCompletedNCT02735980Phase 2Results posted
- A Study of LY2940680 in Small Cell Lung CancerTerminatedNCT01722292Phase 1/2Results posted
- A Study for Participants With Small-Cell Lung CancerCompletedNCT01025284Phase 2Results posted
- Chemotherapy and Radiotherapy to Treat Patients With Limited Stage of Small Cell Lung Cancer (SCLC)TerminatedNCT00494026Phase 2Results posted
- Pemetrexed and Cisplatin as Treatment in Small Cell Lung CancerTerminatedNCT00475657Phase 2Results posted
- A Study to Treat Small Cell Lung Cancer With a Combination of Cisplatin, Pemetrexed, and RadiotherapyTerminatedNCT00447421Phase 1/2Results posted
- Study of Enzastaurin Versus Placebo in the Treatment of Patients With Brain Metastases of Lung Cancer, After Whole Brain Radiation TherapyCompletedNCT00415363Phase 2Results posted
- Study of Pemetrexed and Carboplatin Compared With Etoposide Carboplatin to Treat Extensive-Stage Small Cell Lung CancerCompletedNCT00363415Phase 3Results posted
- A Study of LY4175408 in Participants With Advanced CancerActive, not recruitingNCT07046923Phase 1
- A Study of LY3295668 Erbumine in Participants With Extensive-stage Small-Cell Lung CancerCompletedNCT03898791Phase 1
- Survival in a Randomized Phase III Trial in Patients With Limited Disease (LD) Small Cell Lung Cancer Vaccinated With Adjuvant BEC2 and BCGCompletedNCT00037713Phase 3